CHO’ZILGAN SARIQLIKLARNI BILIRUBIN MIQDORIDAN KLINIK LABORATOR KECHISHI
##article.subject##:
Chaqaloq, cho’zilgan giperbilirubinemiya, metabolik status, prokaltsitonin, S-reaktiv oqsil##article.abstract##
Cho’zilgan giperbilirubinemiya neonatal davrda keng tarqalgan. Neonatal giperbilirubinemiya dolzarbligini tez-tez namoyon bo'lishi hamda boshlanish vaqti va davomiyligi nuqtai nazaridan ham katta munozaralarga sabab bo’lmoqda. Ko'pgina tadqiqotlarga ko'ra, yangi tug'ilgan chaqaloqlarda cho’zilgan giperbilirubinemiya bog’lanmagan bilirubinemiya kuzatilishi bilan ustunlik qiladi, bu jarayon metabolik ravishda qon zardobidagi giperbilirubinemiya kabi metabolik o'zgarishlar bilan tasdiqlanadi.
Библиографические ссылки
American Academy of Pediatrics: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004, 114:297-316.
Burke B.L, Robbins J.M, Bird TM, Hobbs CA, Nesmith C., et al. (2009) Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988–2005. Pediatrics 123:524–532. DOI: 10.1542/ peds.2007-2915 PMID: 19171618.
Boboeva N.T. Differential – diagnostic approach of the etiology and clinical symptoms of prolonged neonatal hyperbilirubinemia. J. Doctor's bulletin 2019№2 pp133-143.
Boboeva N.T. Risk factors for prolonged neonatal jaundice. J. Doctor's bulletin 2019№2 pp 32-35.
Loginova L.A. Features of the course of neonatal jaundice in the modern world. Monograph LAP LAMBERT Academic Publishing (2013-03-11).
Nisevich L.L., Yatsyk G.V., Ashirova A.A., Dvoryakovsky I.V. 1998. Prolonged jaundice in premature infants. Pediatrics. 6: 59-63.
Shabalov N.P/ Neonatology. M.: MEDpress-inform, 2016;12
Volodin H.H., Degtyareva A.B., Degtyarev D.N. The main causes of jaundice in newborns and the principles of differential diagnosis // Ros.Vestnik of perinatology and pediatrics. – 2004. – No. 5. – pp. 18 – 32.
